Pharmaceutical Technology3 小时
PF-07940369 by Pfizer for Anemia: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Pharmaceutical Technology3 小时
PF-07826390 by Pfizer for Colorectal Cancer: Likelihood of Approval
PF-07826390 is under clinical development by Pfizer and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I drugs for Colorectal Cancer have a 75% phase transition success ...